The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
CD36 Deficiency Rescues Lipotoxic Cardiomyopathy
Abstract
Obesity-related diabetes mellitus leads to increased myocardial uptake of fatty acids (FAs), resulting in a form of cardiac dysfunction referred to as lipotoxic cardiomyopathy. We have shown previously that chronic activation of the FA-activated nuclear receptor, peroxisome proliferator-activated receptor α (PPARα), is sufficient to drive the metabolic and functional abnormalities of the diabetic heart. Mice with cardiac-restricted overexpression of PPARα (myosin heavy chain [MHC]-PPARα) exhibit myocyte lipid accumulation and cardiac dysfunction. We sought to define the role of the long-chain FA transporter CD36 in the pathophysiology of lipotoxic forms of cardiomyopathy. MHC-PPARα mice were crossed with CD36-deficient mice (MHC-PPARα/CD36 −/− mice). The absence of CD36 prevented myocyte triacylglyceride accumulation and cardiac dysfunction in the MHC-PPARα mice under basal conditions and following administration of high-fat diet. Surprisingly, the rescue of the MHC-PPARα phenotype by CD36 deficiency was associated with increased glucose uptake and oxidation rather than changes in FA utilization. As predicted by the metabolic changes, the activation of PPARα target genes involved in myocardial FA-oxidation pathways in the hearts of the MHC-PPARα mice was unchanged in the CD36-deficient background. However, PPARα-mediated suppression of genes involved in glucose uptake and oxidation was reversed in the MHC-PPARα/ CD36 −/− mice. We conclude that CD36 is necessary for the development of lipotoxic cardiomyopathy in MHC-PPARα mice and that novel therapeutic strategies aimed at reducing CD36-mediated FA uptake show promise for the prevention or treatment of cardiac dysfunction related to obesity and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, genetic ablation of expression of the FA transporter (CD36) reversed lipotoxicity in PPAR-α overexpressing mice (382).”
From Cardiac remodeling in obesity (2008) · cites this paper as [382]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,115
Myocardial Substrate Metabolism in the Normal and Failing Heart
Stanley, W. C., Recchia, F. A., & Lopaschuk, G. D. (2005) · Physiological Reviews · doi:10.1152/physrev.00006.2004 · Cited by 2,095
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,835
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475 · cited 1×
“Lipotoxic cardiomyopathy has been described in animal models of obesity and diabetes.15,16 In addition, humans with inborn errors in mitochondrial FA oxidation also develop cardiomyopathy associated with myocyte lipid accumulation.42 Proposed mechanisms for the development of cardiac dysfunction secondary to myocyte l…”
BackgroundPGC-1 coactivators: inducible regulators of energy metabolism in health and disease
Finck, B. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27794 · Cited by 1,461
Self-citationLipotoxic heart disease in obese rats: Implications for human obesity
Zhou, Y.-T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1784 · Cited by 1,265
Han, X., & Gross, R. W. (2004) · Mass Spectrometry Reviews · doi:10.1002/mas.20023 · Cited by 1,126
Self-citationThe cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14080 · Cited by 887
Self-citationExpression cloning and characterization of a novel adipocyte long chain fatty acid transport protein
Schaffer, J. E., & Lodish, H. F. (1994) · Cell · doi:10.1016/0092-8674(94)90252-6 · Cited by 868
A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism
Febbraio, M., Abumrad, N. A., Hajjar, D. P., Sharma, K., Cheng, W., Pearce, S. F. A., & Silverstein, R. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19055 · Cited by 769
Self-citationThe cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214080 · Cited by 765
Self-citationA novel mouse model of lipotoxic cardiomyopathy
Chiu, H.-C., Kovács, A., Ford, D. A., Hsu, F., Garcia, R. A., Herrero, P., Saffitz, J. E., & Schaffer, J. E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10947 · Cited by 762
Coburn, C. T., Knapp, F. F., Febbraio, M., Beets, A. L., Silverstein, R. L., & Abumrad, N. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003826200 · Cited by 726
Self-citationManson, J. E. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400060077013 · Cited by 675
Impact of Diabetes on Mortality After the First Myocardial Infarction
Miettinen, H., Lehto, S., Salomaa, V., Mähönen, M., Niemelä, M., Haffner, S. M., Pyörälä, K., Tuomilehto, J., & The FINMONICA Myocardial Infarction Register Study Group (1998) · Diabetes Care · doi:10.2337/diacare.21.1.69 · Cited by 665
The Evolving Diabetes Burden in the United States
Engelgau, M. M., Geiss, L. S., SAADDINE, J. B., Boyle, J. P., Benjamin, S. M., Gregg, E. W., Tierney, E. F., Burrows, N. R., Mokdad, A. H., Ford, E. S., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-11-200406010-00035 · Cited by 658
Mitochondrial energy metabolism in heart failure: a question of balance
Huss, J. M., & Kelly, D. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24405 · Cited by 532
Self-citationMyocardial utilization of carbohydrate and lipids
Neely, J. R., Rovetto, M. J., & Oram, J. F. (1972) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(72)90029-1 · Cited by 509
Coronary Heart Disease Incidence in NIDDM Patients In The Helsinki Heart Study
Koskinen, P., Mänttäri, M., Manninen, V., Huttunen, J. K., Heinonen, O. P., & Frick, M. H. (1992) · Diabetes Care · doi:10.2337/diacare.15.7.820 · Cited by 509
Finck, B. N., Han, X., Courtois, M., Aimond, F., Nerbonne, J. M., Kovacs, A., Gross, R. W., & Kelly, D. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336724100 · Cited by 501
Self-citationAbbott, R. D. (1988) · JAMA · doi:10.1001/jama.260.23.3456 · Cited by 500
Regulation of energy substrate metabolism in the diabetic heart
Stanley, W. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00047-3 · Cited by 480
Transgenic Expression of Fatty Acid Transport Protein 1 in the Heart Causes Lipotoxic Cardiomyopathy
Chiu, H.-C., Kovács, A. D., Blanton, R. M., Han, X., COURTOIS, M. R., Weinheimer, C. J., Yamada, K. A., Brunet, S., Xu, H., Nerbonne, J. M., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000154079.20681.b9 · Cited by 470
Self-citationAltered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice
Belke, D. D., Larsen, T. S., Gibbs, E. M., & Severson, D. L. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e1104 · Cited by 401
Adiposity of the Heart*, Revisited
McGavock, J., Victor, R. G., Unger, R. H., & Szczepaniak, L. S. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-7-200604040-00011 · Cited by 391
Protection of Cardiac Mitochondria by Overexpression of MnSOD Reduces Diabetic Cardiomyopathy
Shen, X., Zheng, S., Metreveli, N. S., & Epstein, P. N. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1039 · Cited by 375
Han, X., & Gross, R. W. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5178 · Cited by 358
Self-citationA current review of fatty acid transport proteins (SLC27)
Stahl, A. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-003-1106-z · Cited by 319
Catalase Protects Cardiomyocyte Function in Models of Type 1 and Type 2 Diabetes
Ye, G., Metreveli, N. S., Donthi, R. V., Shen, X., Xu, M., Carlson, E. C., & Epstein, P. N. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1336 · Cited by 278
Preclinical abnormality of left ventricular function in diabetes mellitus
Ahmed, S. S., Jaferi, G. A., Narang, R. M., & Regan, T. J. (1975) · American Heart Journal · doi:10.1016/0002-8703(75)90039-3 · Cited by 268
Epstein, F. H., Kelly, D. P., & Strauss, A. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301308 · Cited by 255
Self-citationJaffe, A. S., Spadaro, J. J., Schechtman, K. B., Roberts, R., Geltman, E. M., & Sobel, B. E. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90541-6 · Cited by 244
Fatty acid transport proteins: a current view of a growing family
Stahl, A., Gimeno, R. E., Tartaglia, L. A., & Lodish, H. F. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00427-1 · Cited by 239
Cho, E., Rimm, E. B., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02044-2 · Cited by 225
Molecular cloning and functional characterization of KCC3, a new K-Cl cotransporter
Race, J. E., Makhlouf, F. N., Logue, P. J., Wilson, F. H., Dunham, P. B., & Holtzman, E. J. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.6.c1210 · Cited by 223
Cardiac Efficiency Is Improved After Ischemia by Altering Both the Source and Fate of Protons
Liu, B., Clanachan, A. S., Schulz, R., & Lopaschuk, G. D. (1996) · Circulation Research · doi:10.1161/01.res.79.5.940 · Cited by 218
RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload
Rogers, J. H., Tamirisa, P. K., Kovács, A. D., Weinheimer, C. J., COURTOIS, M. R., Blumer, K., Kelly, D. P., & Muslin, A. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6713 · Cited by 197
Self-citationHow fatty acids of different chain length enter and leave cells by free diffusion
Kamp, F., & Hamilton, J. A. (2006) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.05.003 · Cited by 195
Fatty acid transport: the roads taken
Schaffer, J. E. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00462.2001 · Cited by 191
Metabolic Abnormalities in the Diabetic Heart
Lopaschuk, G. D. (2002) · Heart Failure Reviews · doi:10.1023/a:1015328625394 · Cited by 186
Overexpression of Metallothionein Reduces Diabetic Cardiomyopathy
Liang, Q., Carlson, E. C., Donthi, R. V., Kralik, P. M., Shen, X., & Epstein, P. N. (2002) · Diabetes · doi:10.2337/diabetes.51.1.174 · Cited by 182
Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations
Tanaka, T., Nakata, T., Oka, T., Ogawa, T., Okamoto, F., Kusaka, Y., Sohmiya, K., Shimamoto, K., & Itakura, K. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31637-0 · Cited by 158
Cellular fatty acid uptake: the contribution of metabolism
Mashek, D. G., & Coleman, R. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000226119.20307.2b · Cited by 151
Ehehalt, R., Füllekrug, J., Pohl, J., Ring, A., Herrmann, T. R. W., & Stremmel, W. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-9034-1 · Cited by 139
Glucose and fatty acid metabolism in the isolated working mouse heart
Belke, D. D., Larsen, T. S., Lopaschuk, G. D., & Severson, D. L. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.4.r1210 · Cited by 130
Kelly, D. P., Gordon, J. I., Alpers, R., & Strauss, A. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47245-1 · Cited by 117
Self-citationChronic activation of PPARα is detrimental to cardiac recovery after ischemia
Sambandam, N., Morabito, D., Wagg, C. S., Finck, B. N., Kelly, D. P., & Lopaschuk, G. D. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00285.2005 · Cited by 116
Self-citationLopaschuk, G. D., & Spafford, M. A. (1989) · Circulation Research · doi:10.1161/01.res.65.2.378 · Cited by 99
Dichloroacetate improves postischemic function of hypertrophied rat hearts
Wambolt, R. B., Lopaschuk, G. D., Brownsey, R. W., & Allard, M. F. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00856-1 · Cited by 88
Endogenous triacylglycerol metabolism in diabetic heart
Paulson, D. J., & CRASS, M. F. (1982) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1982.242.6.h1084 · Cited by 86
Panagia, M., Gibbons, G. F., Radda, G. K., & Clarke, K. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00200.2004 · Cited by 75
Activation of a novel metabolic gene regulatory pathway by chronic stimulation of skeletal muscle
Cresci, S., Wright, L. D., Spratt, J. A., Briggs, F. N., & Kelly, D. P. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.270.5.c1413 · Cited by 69
Self-citationTaniguchi, M., Wilson, C., Hunter, C. A., Pehowich, D. J., Clanachan, A. S., & Lopaschuk, G. D. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.4.h1762 · Cited by 54
Cardiomyocyte Dysfunction in Models of Type 1 and Type 2 Diabetes
Kralik, P. M., Ye, G., Metreveli, N. S., Shen, X., & Epstein, P. N. (2005) · Cardiovascular Toxicology · doi:10.1385/ct:5:3:285 · Cited by 50
Schuler, A. M., Gower, B. A., Matern, D., Rinaldo, P., & Wood, P. A. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.08.010 · Cited by 9
Cardiac drug effects on lipids
Lardinois, C. K., & Johns, J. P. (1992) · Current Opinion in Lipidology · doi:10.1097/00041433-199208000-00005 · Cited by 5
Cited by
Sorted by citations
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,228
Jia, G., Hill, M. A., & Sowers, J. R. (2018) · Circulation Research · doi:10.1161/circresaha.117.311586 · Cited by 1,872
Diabetic Cardiomyopathy Revisited
Boudina, S., & Abel, E. D. (2007) · Circulation · doi:10.1161/circulationaha.106.679597 · Cited by 1,543
CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior
Silverstein, R. L., & Febbraio, M. (2009) · Science Signaling · doi:10.1126/scisignal.272re3 · Cited by 1,141
Self-citationTan, Y., Zhang, Z., Zheng, C., Wintergerst, K. A., Keller, B. B., & Cai, L. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0339-2 · Cited by 862
Metadata
- Authors
- Yang, J., Sambandam, N., Han, X., Gross, R. W., Courtois, M., Kovacs, A., Febbraio, M., Finck, B. N., & Kelly, D. P.
- Affiliations
- Cleveland Clinic (US)
- From the Center for Cardiovascular Research (J.Y., N.S., R.W.G., M.C., A.K., D.P.K.) and Departments of Medicine (J.Y., N.S., X.H., R.W.G., M.C., A.K., B.N.F., D.P.K.), Molecular Biology & Pharmacology (R.W.G., D.P.K.), and Pediatrics (D.P.K.), Washington University School of Medicine, St Louis, Mo; and Department of Cell Biology (M.F.), Lerner Research Institute, Cleveland Clinic, Ohio.
- Venue
- Circulation Research
- Published
- 2007-04-27
- Volume
- 100
- Issue
- 8
- Pages
- 1208-1217
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2160476964
- Cited by
- 246
- References
- 57
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 10 · 2023: 5 · 2022: 11 · 2021: 13 · 2020: 13 · 2019: 7 · 2018: 18 · 2017: 12 · 2016: 16 · 2015: 14 · 2014: 11 · 2013: 12 · 2012: 22
- FWCI
- 7.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL57278, P01HL057278, P50HL077113, K08HL076452, KO8 HL076452)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK-52574, P30-DK56341, P30DK056341, P30DK052574)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- CD36, lipotoxic cardiomyopathy, PPARα, fatty acid uptake, cardiac dysfunction, triglyceride accumulation, glucose uptake, glucose oxidation, fatty acid oxidation, obesity, diabetes mellitus, myosin heavy chain, high-fat diet, myocardial lipid metabolism
- MeSH terms
- Animals, Diabetic Angiopathies, Fatty Acids, Glucose, Mice, Inbred C57BL, Mice, Transgenic, Obesity, Oxidation-Reduction, Phenotype, Mice, Knockout, CD36 Antigens, PPAR alpha, Adiposity, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review